Page last updated: 2024-11-02

orphenadrine and Spinal Cord Injuries

orphenadrine has been researched along with Spinal Cord Injuries in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).

Research Excerpts

ExcerptRelevanceReference
"One patient with severe spastic hypertonia leading to triple flexion when the limb was manipulated did not gain any relief with orphenadrine."2.68Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. ( Buonocore, M; Casale, R; Glynn, CJ, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casale, R1
Glynn, CJ1
Buonocore, M1

Trials

1 trial available for orphenadrine and Spinal Cord Injuries

ArticleYear
Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo.
    Archives of physical medicine and rehabilitation, 1995, Volume: 76, Issue:7

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Intravenous; Leg; Male;

1995